Is the standard dose of amoxicillin-clavulanic acid sufficient?

Haeseker, Michiel; Havenith, Thomas; Stolk, Leo; Neef, Cees; Bruggeman, Cathrien; Verbon, Annelies
July 2014
BMC Pharmacology & Toxicology;2014, Vol. 15 Issue 1, p38
Academic Journal
Background: The pharmacodynamic (PD) efficacy target of amoxicillin is 40% time above the minimal inhibition concentration (40%T > MIC). Recent studies of other antibiotics have shown that PD-efficacy targets are not always reached. The aim of this study was to evaluate the percentage of hospitalised patients, using amoxicillin/clavulanic acid intravenously (iv), that reach the pharmacodynamic efficacy target 40%T > MIC. Additionally, the association of demographic anthropomorphic and clinical parameters with the pharmacokinetics and pharmacodynamics of amoxicillin were determined. Methods: In serum of 57 hospitalised patients amoxicillin concentrations were measured using high performance liquid chromatography. Patients were older than 18 years and most patients had an abdominal infection. The standard amoxicillin/clavulanic acid dose was 4 times a day 1000/200 mg iv. Pharmacokinetic parameters were calculated with maximum a posteriori Bayesian estimation (MW\Pharm 3.60). A one-compartment open model was used. Individual dosing simulations were performed with MW\Pharm. Results: In our study population, the mean (±SD) age was 67 (±16) years and the mean clearance corrected for bodyweight was 0.17 (±0.07) L/h/kg. Only, 65% of the patients reached the proposed amoxicillin 40%T > MIC with amoxicillin/clavulanic acid for bacterial MICs of 8 mg/L. A computer simulated increase of the standard dose to 6 times daily, increased this percentage to 95%. In this small study group 40%T > MIC was not associated with clinical or microbiological cure. Conclusion: A substantial proportion of the hospitalised patients did not reach the 40%T > MIC with the standard dose amoxicillin/clavulanic acid for a bacterial MIC of 8 mg/L. Therefore, we suggest increasing the standard dose of amoxicillin/clavulanic acid to 6 times a day in patients with severe Enterobacteriaceae infections.


Related Articles

  • Amoxicillin/Clavulanic Acid 2000mg/125mg Extended Release (XR): A Review of its Use in the Treatment of Respiratory Tract Infections in Adults. McCormack, Paul L.; Keating, Gillian M. // Drugs;2005, Vol. 65 Issue 1, p121 

    Amoxicillin/clavulanic acid 2000mg/125mg extended release (Augmentin XRâ„¢), referred to herein as amoxicillin/clavulanic acid XR, is a pharmacokinetically enhanced formulation designed to provide more effective therapy in adults and adolescents than conventional formulations against...

  • Do you need only three days to treat an uncomplicated UTI?  // Veterinary Medicine;Sep2012, Vol. 107 Issue 9, p386 

    The presents a prospective, multicenter, controlled, randomized, and blinded clinical trial on the treatment of bacterial urinary tract infections (UTIs) in dogs. The study shows that a high-dose, short-duration enrofloxacin protocol was not inferior to a standard amoxicillin-clavulanic acid...

  • Amoxicillin/clavulanic acid.  // Reactions Weekly;1/9/2010 Part 1 of 2, Issue 1283, p11 

    The article describes the case of a 13-year-old girl who developed acute generalised exanthematous pustulosis (AGEP) while under amoxicillin/clavulanic acid treatment regimen for Staphylococcus aureus infection. After receiving two doses of amoxicillin/clavulanic acid, the patient developed...

  • Short term antibiotic prophylaxis for emergency cesarean delivery : Is there a difference? Shetty, Jyothi; Rajshekhar, Smita; Kamath, Asha // Internet Journal of Gynecology & Obstetrics;2009, Vol. 11 Issue 1, p18 

    Objective : To evaluate the efficacy of amoxicillin-clavulanic acid when given as a two dose versus the more traditional triple dose regimen for cesarean section prophylaxis. Methods : We conducted a prospective study of 122 women undergoing emergency cesarean section. All patients received 2.4...

  • Population pharmacokinetics and dosing simulations of amoxicillin/clavulanic acid in critically ill patients. Carlier, Mieke; Noë, Michaël; De Waele, Jan J.; Stove, Veronique; Verstraete, Alain G.; Lipman, Jeffrey; Roberts, Jason A. // Journal of Antimicrobial Chemotherapy (JAC);Nov2013, Vol. 68 Issue 11, p2600 

    Objectives The objective of this study was to investigate the population pharmacokinetics and pharmacodynamics of amoxicillin and clavulanic acid in critically ill patients. Methods In this observational pharmacokinetic study, multiple blood samples were taken over one dosing interval of...

  • Amoxicillin/clavulanic acid.  // Reactions Weekly;10/13/2012, Issue 1423, p8 

    The article describes two cases of patients who developed anaphylactic reaction while undergoing amoxicillin/clavulanic acid therapy.

  • Various drugs.  // Reactions Weekly;8/14/2010, Issue 1314, p41 

    The article describes four cases of liver injury caused by alfuzosin, paracetamol/codeine or amoxicillin/clavulanic acid.

  • Amoxicillin/clavulanic acid.  // Reactions Weekly;8/21/2010, Issue 1315, p11 

    The article describes several cases of patients who developed hypersensitivity while receiving treatment with amoxicillin/clavulanic acid.

  • Amoxicillin/clavulanic acid.  // Reactions Weekly;Jan2015, Vol. 1533 Issue 1, p39 

    An abstract of the article "Case report : Amoxicillin/clavulanic acid-induced thrombocytopenia," by H. Mansour and colleagues is presented.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics